Search results for: 'defin tech eu'

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

20 Feb 2020  |  Europe  |  Market Outlook

EU Healthcare Predictions and Outlook, 2020

Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing to be Key Drivers of Growth

Infographics

×

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national health...

02 Nov 2022  |  North America  |  Market Research

Strategic Insights and Growth Opportunities for Software-defined Vehicles

Future Growth Potential in the Automotive Industry Hinges on a Service-oriented Architecture with Repeatable Avenues of Revenue Generation

Infographics

×

Key Issues Addressed

Original equipment manufacturers (OEMs) used to differentiate their products based on mechanical features. Today, however, consumers are increasingly looking for features defined by software, such as driver assistance, connectivity, and comfort-convenience services. The convergence of technologies including electrification, autonomous driving, shar...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

28 May 2021  |  Global  |  Market Research

In-vehicle Edge Tech and 5G to Make MEC the Prime Processing Hub

Future Growth Potential of MEC in Automotive Applications

Infographics

×

Multi-access Edge Computing (MEC) in automotive is in its early stage and this report is considered to be an overview of the automotive edge computing market. This study defines Multi-Access Edge Computing for the automotive industry and covers how automotive stakeholders should anticipate new applications on both existing and future business mode...

26 May 2020  |  North America  |  Market Research

US and EU-5 Custom Procedure Tray Market, Forecast to 2024

Healthcare Systems Benefit from Standardization and Efficiency

Infographics

×

Escalating healthcare costs and longer patient wait lists have put pressure on healthcare facilities to reduce operational expenses and increase efficiency. The operating room is one of the biggest cost (and revenue) centers for a healthcare facility: according to some studies, the operating room accounts for about 40Percentage of expenses in a hos...

The report provides an indepth analysis of each trend, outlining market demands, drivers and restraints, growth opportunities, and use cases. This will help vendors analyze the market, evaluate their market positioning, and take appropriate action to become global leaders.--BEGIN PROMO--Research Scope This study examines the market scenario and ...

This issue of High-Tech Materials Technology Opportunity Engine (TOE) profiles significant advancements in high-tech materials for various enhanced industrial applications. The featured innovations include Recycling Polystyrene to Produce Sustainable Surface Materials, Seaweed-based Sustainable and Biodegradable Packaging, High-performance Plant-ba...

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...